Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules

[1]  M. Tafani,et al.  Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms , 2023, International journal of molecular sciences.

[2]  Shi-Tong Yu,et al.  SYTL5 promotes papillary thyroid carcinoma progression by enhancing activation of the NF-κB signaling pathway. , 2022, Endocrinology.

[3]  Qing Liu,et al.  Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. , 2022, International journal of surgery.

[4]  L. Fu,et al.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies , 2022, Signal Transduction and Targeted Therapy.

[5]  Feixiang Ding,et al.  Restoration of the Immunogenicity of Tumor Cells for Enhanced Cancer Therapy via Nanoparticle‐Mediated Copper Chaperone Inhibition , 2022, Angewandte Chemie.

[6]  M. Mizuno-Kamiya,et al.  The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas , 2022, Cancers.

[7]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[8]  A. Casini,et al.  Connecting copper and cancer: from transition metal signalling to metalloplasia , 2021, Nature Reviews Cancer.

[9]  Jiucun Wang,et al.  Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma , 2021, Nature Communications.

[10]  E. Heath,et al.  Prostate cancer dormancy and recurrence. , 2021, Cancer letters.

[11]  C. Fischbach,et al.  Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer , 2021, NPJ breast cancer.

[12]  Li Tang,et al.  Cytokine engineering for targeted cancer immunotherapy. , 2021, Current opinion in chemical biology.

[13]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[14]  Correction: Consensus guidelines for the definition, detection and interpretation of immunogenic cell death , 2020, Journal for immunotherapy of cancer.

[15]  P. Hegde,et al.  Top 10 Challenges in Cancer Immunotherapy. , 2020, Immunity.

[16]  P. Timpson,et al.  Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. , 2019, Cancer letters.

[17]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[18]  X. Su,et al.  Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome1 , 2019, Neoplasia.

[19]  P. Vandenabeele,et al.  The molecular machinery of regulated cell death , 2019, Cell Research.

[20]  Xiaosheng Wang,et al.  Classification of triple-negative breast cancers based on Immunogenomic profiling , 2018, Journal of experimental & clinical cancer research : CR.

[21]  Q. Wang,et al.  Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies. , 2018, Cancer letters.

[22]  A. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[23]  X. Liu,et al.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.

[24]  Cheng Huang,et al.  NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. , 2016, Cancer letters.

[25]  Qiang Z Yu,et al.  Apoptosis, autophagy, necroptosis, and cancer metastasis , 2015, Molecular Cancer.

[26]  M. Tan,et al.  The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. , 2015, Cancer letters.

[27]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[28]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[29]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[30]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[31]  Hui Yang,et al.  Nimesulide inhibits IFN-gamma-induced programmed death-1-ligand 1 surface expression in breast cancer cells by COX-2 and PGE2 independent mechanisms. , 2009, Cancer letters.

[32]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Hassan,et al.  Interferon (IFN)-beta induces apoptotic cell death in DHL-4 diffuse large B cell lymphoma cells through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). , 2005, Cancer letters.

[34]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[35]  H. Zhan,et al.  Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion. , 2019, Cancer letters.